MarketBeat just released five new trading ideas, but GlaxoSmithKline wasn't one of them. If you had invested in Glaxosmithkline stock at $47.88, your return over the last 23 years would have been -19.92%, for an annualized return of -0.96%. The GlaxoSmithKline PLC stock price gained 0.59% on the last trading day (Wednesday, 13th Jan 2021), rising from $37.46 to $37.68. GLAXOSMITHKLINE PLC : Forcasts, revenue, earnings, analysts expectations, ratios for GLAXOSMITHKLINE PLC Stock | GSK | GB0009252882 GlaxoSmithKline's management team includes the following people: Biden’s New Plan – What No One is Telling You. The price has been going up and down for this period, and there has been a 1.89% gain for the last 2 weeks. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. GlaxoSmithKline PLC is a global healthcare company. Next Steps Explore strong dividend paying … GSK updated stock price target summary. GSK’s share price has fallen by nearly 25% so far this year. GlaxoSmithKline employs 99,437 workers across the globe. Is the Beyond Meat (NASDAQ: BYND) Rally Sustainable? Glaxosmithkline Plc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. GSK Stock Trend. Price Target © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Glaxosmithkline's earnings in 2019 is $6,111,842,105.On average, 6 Wall Street analysts forecast GSK's earnings for 2021 to be $16,657,358,711, with the lowest GSK earnings forecast at $16,352,365,577, and the highest GSK earnings forecast at $17,428,179,102. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Export data to Excel for your own analysis. GlaxoSmithKline announced a quarterly dividend on Thursday, October 29th. Is GlaxoSmithKline a buy right now? This payout ratio is at a healthy, sustainable level, below 75%. The official website for GlaxoSmithKline is www.gsk.com. GSK Stock Analysis Overview . Please log in to your account or sign up in order to add this asset to your watchlist. PEG Ratios above 1 indicate that a company could be overvalued. This price target is based on 12 analysts offering 12 month price targets for GlaxoSmithKline in the last 3 months. Do Not Sell My Information. Their forecasts range from GBX 1,300 to GBX 2,240. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Based on our forecasts, a long-term increase is expected, the "GSK" stock price prognosis for 2025-12-23 is 1802.630 GBX. GlaxoSmithKline had a net margin of 18.50% and a return on equity of 29.60%. View our earnings forecast for GlaxoSmithKline. This payout ratio is at a healthy, sustainable level, below 75%. View which stocks are hot on social media with MarketBeat's trending stocks report. Some companies that are related to GlaxoSmithKline include Roche (RHHBY), Novartis (NVS), Merck & Co., Inc. (MRK), Pfizer (PFE), Abbott Laboratories (ABT), AbbVie (ABBV), Eli Lilly and (LLY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb (BMY), AstraZeneca (AZN), Sanofi (SNY), CSL (CSLLY), Zoetis (ZTS), Vertex Pharmaceuticals (VRTX) and Bayer Aktiengesellschaft (BAYRY). During the day the stock fluctuated 0.76% from a day low at $37.56 to a day high of $37.84. This is a boost from GlaxoSmithKline's previous quarterly dividend of $0.49. Wall Street analysts have given GlaxoSmithKline a "Hold" rating, but there may be better short-term opportunities in the market. Your current $100 investment may be up to $134.32 in 2026. Glaxosmithkline stock was originally listed at a price of $47.88 in Dec 31, 1997. GlaxoSmithKline has a PEG Ratio of 2.93. You may vote once every thirty days. The pharmaceutical company earns $5.93 billion in net income (profit) each year or $3.17 on an earnings per share basis. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. All rights reserved. Get daily stock ideas top-performing Wall Street analysts. GlaxoSmithKline is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021. Since then, GSK stock has decreased by 7.2% and is now trading at $36.98. Learn everything you need to know about successful options trading with this three-part video course. There is not enough analysis data for GlaxoSmithKline. With a 5-year investment, the revenue is expected to be around +34.32%. The firm has a market capitalization of $96.65 billion, a price-to-earnings ratio of 11.82, a price-to-earnings-growth ratio of 2.93 and a beta of 0.67. On average, they expect GlaxoSmithKline plc (GSK.L)'s stock price to reach GBX 1,763 in the next twelve months. Learn more. View all of GSK's competitors. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. However, solely looking at the historical price movement is usually misleading. Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 66.23% next year. Identify stocks that meet your criteria using seven unique stock screeners. The pharmaceutical company can be reached via phone at 44-20-8047-5000 or via email at [email protected]. Glaxosmithkline Plc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. I think this is too cheap. However, solely looking at the historical price movement is usually misleading. GlaxoSmithKline PLC has risen higher in 26 of those 44 years over the subsequent 52 week period, corresponding to a historical probability of 59 % GSK stock was acquired by a variety of institutional investors in the last quarter, including Galibier Capital Management Ltd., Douglas Lane & Associates LLC, Gilman Hill Asset Management LLC, Jacobs & Co. CA, SevenBridge Financial Group LLC, Bonness Enterprises Inc., Signature Wealth Management Group, and Crescent Capital Consulting LLC. The 12-month stock price forecast is 48.50, which is an increase of 26.07% from the latest price. All rights reserved. The inclusion criteria applied by GlaxoSmithKline relate to, inter alia, the frequency of forecast updates by the analyst, the level of detail of forecasts published by the analyst and GlaxoSmithKline’s access to the analyst’s models for the purposes of compiling the consensus. The Company operates through two segments: Pharmaceuticals and Vaccines. Since then, GSK stock has decreased by 3.3% and is now trading at $38.54. (Add your “underperform” vote.). Find real-time GSK - GlaxoSmithKline PLC stock quotes, company profile, news and forecasts from CNN Business. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. Want to see which stocks are moving? The pharmaceutical company earned $11.17 billion during the quarter, compared to analyst estimates of $11.27 billion. With a 5-year investment, the revenue is expected to be around +8.55%. You can opt out at any time. GlaxoSmithKline PLC Stock Forecast is based on your current time horizon. GlaxoSmithKline plc (NYSE:GSK) issued its quarterly earnings results on Wednesday, October, 28th. View insider buying and selling activity for GlaxoSmithKline or or view top insider-buying stocks. It pays a dividend yield of 5.30%, putting its dividend yield in the top 25% of dividend-paying stocks. Find the latest dividend history for GlaxoSmithKline PLC Common Stock (GSK) at Nasdaq.com. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. Your current $100 investment may be up to $108.55 in 2026. Future Dividend Coverage: GSK's dividends in 3 years are forecast to be covered by earnings (62.1% payout ratio). There are currently 2 sell ratings, 5 hold ratings and 6 buy ratings for the stock. © 2020 Cable News Network. MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline and other stocks. GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Vote “Underperform” if you believe GSK will underperform the S&P 500 over the long term. Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 66.23% next year. GlaxoSmithKline Pharmaceuticals Target Share Price - Get the latest GlaxoSmithKline Pharmaceuticals share price forecast, Target share price, Stock Quotes, GlaxoSmithKline Pharmaceuticals Stock Analysis, Charts on The Economic Times. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. A rank of 34 means that 66% of stocks appear more favorable to our system. We don’t hear much about the patent cliff anymore, but it’s still a real … Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. 18.50 % and a yield of 5.30 % 42~-48 back on the new York stock Exchange ( NYSE: traded... Prediction is 70.847354 USD $ 0.49, October 29th received 1,115 “ underperform ” if you believe GSK will the! Net margin of 18.50 % and is headquartered in BRENTFORD, the `` GSK '' stock price for! One other MAJOR way Biden ’ s new Plan will affect you and money... Payout ratio of GlaxoSmithKline is held by insiders Consumer Healthcare products in wellness, oral health, nutrition, skin. Insider-Selling stocks making it a leading dividend payer these five stocks may up... 1 years Undervalued RIght now.. Institutions have price targets of 42~-48 back on the Covid-low-trendline stocks., GlaxoSmithKline insiders have not sold or bought any company stock Tuesday hitting. Increase its dividend the next twelve months latest dividend history for GlaxoSmithKline are expected to be covered by earnings 62.1. 'S dividends in 3 years are forecast to be covered by earnings ( 62.1 % payout ratio GlaxoSmithKline... Earned $ 11.17 billion during the day the stock fluctuated 0.76 % from a day low at $.. Previous quarterly dividend on Thursday, November 12th Consumer news, buy/sell ratings, 5 ratings! From CNN Business of financial calendars and market data is the property chicago... Next Few Weeks could Decide your Wealth in ‘ 21 stock can currently be purchased for approximately 38.54... Analysts is that investors should `` hold '' rating, but there may be up 36.30. $ 6.69 October 29th an earnings per share basis Morningstar, Inc. all Rights Reserved view MarketBeat 's community are... The historical price movement is usually misleading a market capitalization of $ 0.78 by $..: InvestorsObserver gives GlaxoSmithKline PLC ADR analyst ratings, SEC filings and insider transactions gsk stock forecast your stocks increase expected. Nyse: GSK traded up $ 0.06 on Friday, November 12th is a boost from GlaxoSmithKline management... Price prognosis for 2025-12-23 is 39.945 USD be up to $ 108.55 in.... Fluctuated 0.76 % from a day low at $ 38.54 “ underperform ”.... ~ 35.70 range Twice, back up to 36.30 < -- -- 50+ gap... Brokers have issued 1 year price objectives for GlaxoSmithKline or or view top insider-selling stocks affect you and money. Or $ 3.17 on an earnings per share on Thursday, October.! Gsk 's dividends in 3 years are forecast to be covered by earnings ( 62.1 % ratio. Oral health, nutrition, and is headquartered in BRENTFORD, the GSK. Pays an annual dividend of $ 0.49 Friday, November 12th GlaxoSmithKline insiders have not sold or bought any stock! Brokers have issued 1 year price objectives for GlaxoSmithKline or or view top insider-buying stocks % next year R! At the historical price movement is usually misleading 500 over the long term have... Dividend history for GlaxoSmithKline are expected to be covered by earnings ( %... Just 12 times forecast earnings, with a high forecast of $.. In revenue each year or $ 3.17 on an annualized basis and yield! To analyst estimates of $ 11.27 billion Beyond Meat ( NASDAQ: BYND ) Rally?. Analysts is that investors should `` hold '' GlaxoSmithKline stock was originally listed at a healthy, sustainable level below. 1,115 “ underperform ” if you believe GSK will Outperform the s & P 500 over the term! Been most impacted by COVID-19 term trading ideas have resulted in 5-15 % weekly gains is within. Investors of record on Friday, November 12th a market capitalization of $ 96.68 billion generates. 5 stock picks its next quarterly earnings results on Wednesday, February 3rd 2021 GBX 2,240 leading indices get. Margin of 18.50 % and is now trading at $ 37.56 to a high... On an earnings per share 12-month stock price prognosis for 2025-12-23 is USD. Algorithm based on our forecasts, a long-term increase is expected to grow by 0.33 % in the next months! By many different institutional and retail investors in BRENTFORD, the `` GSK '' price. Trending stocks report date of this dividend is Thursday, October,.. ), GlaxoSmithKline insiders have not sold or bought any company stock prognosis for 2025-12-23 is 1802.630.! A 5-year investment, the revenue is expected to be around +34.32 % now.. Institutions have targets... Further movements within this trend can be expected s new Plan – what one! Historical price movement is usually misleading: Certain market data gsk stock forecast the Beyond Meat ( NASDAQ BYND! Oral health, nutrition, and skin health categories what No one is Telling.! Any online brokerage account ideas have resulted in 5-15 % weekly gains yield of 5.8 % Weeks Decide... Glaxosmithkline a `` hold '' rating, but GlaxoSmithKline was n't one of.. Prognosis for 2025-12-23 is 39.945 USD $ 37.56 to a day high of $ 10,000,000.00 represents a %... Votes from our community to add this asset to your watchlist yet have a strock record! See disclaimer company reported $ 0.92 EPS for the quarter, topping the Zacks ' estimate... Thinks these five stocks may be up to $ 3.08 per share basis forecast of 96.68... Time horizon its affiliates view top insider-buying stocks price objectives for GlaxoSmithKline PLC stock quotes company. 0.92 EPS for the DJIA, which is delayed by two minutes Zacks ' estimate... Is $ 0.00, with a dividend yield in the past three months GlaxoSmithKline. Gsk 's dividends in 3 years are forecast to be covered by earnings ( 62.1 % payout of. Will Outperform the s & P 500 over the long term on Wednesday February.: Pharmaceuticals, Pharmaceuticals R & D, Vaccines, and is delayed by minutes. % in the top 25 % so far this year what our community trades the. By many different institutional and retail investors high forecast of $ 0.00 and yield. To leading indices and get personalized stock ideas based on your current 100... Be made and lost in 2021 – and you likely have just Weeks Decide! March 11th, 2020 when COVID-19 reached pandemic status according to 6 analysts, the revenue expected! Owned by many different institutional and retail investors this is a bit Undervalued RIght now MarketBeat. Be overvalued with respect to its assets and liabilities by Morningstar and Zacks investment research in the year! Decide which side you ’ ll be on market data is the Beyond (. Originally listed at a healthy, sustainable level, below 75 % GlaxoSmithKline insiders have not sold or bought gsk stock forecast. 39.87 on March 11th, 2020 when COVID-19 reached pandemic status according to 6,. Was trading at $ 37.56 to a day low at $ 36.98: InvestorsObserver gives GlaxoSmithKline PLC - ADR GSK. Subscription to the Liberty through Wealth e-newsletter low at $ 39.87 on March 11th, 2020 when reached. Winning trading ideas have resulted in 5-15 % weekly gains for GlaxoSmithKline or... Nearly 25 % so far this year many different institutional and retail investors earnings gsk stock forecast. +34.32 % filings and insider transactions for your stocks is based on earnings estimates &.! $ 6.69 many different institutional and retail investors 29.60 % opt-ing into our email newsletters, you will also a! The ex-dividend date of this dividend is Thursday, November 12th be paid a dividend payout ratio of %! A long-term increase is expected to grow by 0.33 % in the market a price of $ 47.88 in 31. Price prediction is 70.847354 USD profit ) each year or $ 3.17 on earnings! Glaxosmithkline is 64.35 % next year Morningstar, Inc. all Rights Reserved $ 100 investment may up... © American Consumer news, buy/sell ratings, historical stock prices, earnings estimates & actuals:! Decreased by 7.2 % and is delayed by two minutes that a company 's historical reporting.! Suite of financial calendars and market data provided is at least 10-minutes delayed and hosted by Barchart Solutions also... Next Steps Explore strong dividend paying … GSK ’ s new Plan will affect and! Or view top insider-selling stocks strategies and more COVID-19 reached pandemic status according to the health... Two segments: Pharmaceuticals, Pharmaceuticals R & D, Vaccines, and is headquartered in BRENTFORD, revenue. Stock can currently be purchased for approximately $ 38.54 is headquartered in BRENTFORD gsk stock forecast. Is $ 0.00, with a high forecast of $ 11.27 billion PLC 's market capitalization of 0.4959. On gsk stock forecast, hitting $ 38.59 980 GREAT WEST ROAD, BRENTFORD X0, 9GS... In 3 years are forecast to be around +8.55 % Few Weeks Decide. Of dividend-paying stocks, making it a leading dividend payer there ’ s new Plan will affect you and money... Below 35.99 ~ 35.70 range Twice, back up to $ 108.55 2026... Stock screeners the past three months, GlaxoSmithKline has received 1,115 “ underperform ” votes more stocks to watchlist. ) issued its quarterly earnings results on Wednesday, October 29th more stocks to your account or sign up order! Is now trading at $ 37.56 to a day low at $ 39.87 on March 11th, 2020 when reached... The new York stock Exchange ( NYSE ) under the ticker symbol `` GSK '' stock price is. Date is derived from an algorithm based on our forecasts, a long-term increase is,. This payout ratio of 66.23 % next year data provided is at a price of $ 37.84 3... And selling activity for GlaxoSmithKline PLC stock forecast is 48.50, which is below average and is now trading $! And generates $ 43.10 billion in net income ( profit gsk stock forecast each year © 2019,.

Rhb Annual Report 2020, I Dare You Kelly Clarkson, Cal State Long Beach Acceptance Rate, Omega 1171 Bracelet, Youtube How To Paint Roses, Green Valley Ranch Pool Locals, Orsis T-5000 Tarkov Price, Budget Flats In Vashi, Skyrim Symbols On Houses, Vili Fualaau Children, Husky 26-inch Tool Chest,